ANTI-CD123 CHIMERIC ANTIGEN RECEPTOR REDIRECTED T CELLS FOR RELAPSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

被引：0
|
作者：
Ruella, M. [1 ]
Shestova, O. [1 ]
Kenderian, S. [1 ]
Barrett, D. [2 ]
Grupp, S. [2 ]
Scholler, J. [1 ]
Lacey, S. [1 ]
Kalos, M. [1 ]
June, C. H. [1 ]
Gill, S. [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
来源：
CYTOTHERAPY | 2014年 / 16卷 / 04期
关键词：
D O I：
10.1016/j.jcyt.2014.01.017
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
5
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [21] Sequential treatment with anti-CD19 and CD22 chimeric antigen receptor T cells in children with relapsed or refractory B acute lymphoblastic leukemia
    Chanut, Mathilde
    HEMATOLOGIE, 2023, 29 (06): : 332 - 334
  • [22] Balance of Anti-CD123 Chimeric Antigen Receptor (CAR) Binding Affinity and Density for the Treatment of Acute Myeloid Leukemia
    Arcangeli, Silvia
    Bardelli, Marco
    Rotiroti, Maria Caterina
    Simonelli, Luca
    Magnani, Chiara F.
    Varani, Luca
    Biondi, Andrea
    Biagi, Ettore
    Tettamanti, Sarah
    BLOOD, 2016, 128 (22)
  • [23] BALANCE OF ANTI-CD123 CHIMERIC ANTIGEN RECEPTOR (CAR) BINDING AFFINITY AND DENSITY FOR THE TARGETING OF ACUTE MYELOID LEUKEMIA
    Arcangeli, S.
    Rotiroti, M.
    Bardelli, M.
    Simonelli, L.
    Magnani, C.
    Varani, L.
    Biondi, A.
    Tettamanti, S.
    Biagi, E.
    CYTOTHERAPY, 2017, 19 (05) : S8 - S8
  • [24] Chimeric antigen receptor T cells for acute lymphoblastic leukemia
    Frey, Noelle V.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 : S24 - S27
  • [25] Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia
    Zhao Xiangyu
    Wu Haotian
    Cheng Yifei
    Xu Zhengli
    Chen Yuhong
    Chang Yingjun
    Wang Yu
    Zhang Xiaohui
    Xu Lanping
    Huang Xiaojun
    中华医学杂志英文版, 2023, 136 (16)
  • [26] Granulocyte Transfusions in a Patient with Relapsed B-Cell Acute Lymphoblastic Leukemia Status Post Chimeric Antigen Receptor T-Cell Therapy
    Briski, Laurence M.
    Siegfried, Barry
    Yamada, Chisa
    TRANSFUSION, 2017, 57 : 173A - 174A
  • [27] Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia
    Zhao, Xiangyu
    Wu, Haotian
    Cheng, Yifei
    Xu, Zhengli
    Chen, Yuhong
    Chang, Yingjun
    Wang, Yu
    Zhang, Xiaohui
    Xu, Lanping
    Huang, Xiaojun
    CHINESE MEDICAL JOURNAL, 2023, 136 (16) : 2011 - 2013
  • [28] Cost-Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
    Sarkar, Reith R.
    Gloude, Nicholas J.
    Schiff, Deborah
    Murphy, James D.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2019, 111 (07): : 719 - 726
  • [29] Advances in the development of chimeric antigen receptor-T-cell therapy in B-cell acute lymphoblastic leukemia
    Zhang, Xian
    Li, Jing-Jing
    Lu, Pei-Hua
    CHINESE MEDICAL JOURNAL, 2020, 133 (04) : 474 - 482
  • [30] Influence of patient characteristics on chimeric antigen receptor T cell therapy in B-cell acute lymphoblastic leukemia
    An, Furun
    Wang, Huiping
    Liu, Zhenyun
    Wu, Fan
    Zhang, Jiakui
    Tao, Qianshan
    Li, Yingwei
    Shen, Yuanyuan
    Ruan, Yanjie
    Zhang, Qing
    Pan, Ying
    Zhu, Weiwei
    Qin, Hui
    Wang, Yansheng
    Fu, Yongling
    Feng, Zhenqing
    Zhai, Zhimin
    NATURE COMMUNICATIONS, 2020, 11 (01)
12345